Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

Date publication

avril 2005

Journal

Clinical radiology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis , Pr LEJEUNE Catherine , Pr WORONOFF Macha

Tous les auteurs :
Alzahouri K, Lejeune C, Woronoff-Lemsi MC, Arveux P, Guillemin F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/15767106

Résumé

To determine the most cost-effective strategy using PET for mediastinal staging of potentially operable non-small-cell lung cancer (NSCLC).

Mots clés

Aged, Biopsy, economics, Carcinoma, Non-Small-Cell Lung, diagnostic imaging, Cost-Benefit Analysis, economics, Decision Trees, France, Humans, Insurance, Health, economics, Life Expectancy, Lung Neoplasms, diagnostic imaging, Lymphatic Metastasis, Neoplasm Staging, methods, Positron-Emission Tomography, economics, Sensitivity and Specificity, Tomography, X-Ray Computed, economics

Référence

Clin Radiol. 2005 Apr;60(4):479-92